WHO R&D Blueprint – Ad-hoc workshop on Ebola Vaccines - Deliberations on design options for clinical trials to assess the safety and efficacy of investigational Ebola vaccines

Overview

The objectives of this consultation were:

(i) to review and discuss the existing body of evidence of the most advanced candidate vaccines;

(ii) to review trial design options and exchange views on potential study design options to be implemented in the context of the current EVD outbreak;

(iii) to discuss criteria that could inform national authorities of affected countries on the adequate candidate Ebola vaccines to be selected for evaluation under the proposed clinical trials and;

(iv) to discuss a framework for an efficient and sustainable collaborative approach across countries and this and future outbreaks.